<DOC>
	<DOCNO>NCT02506101</DOCNO>
	<brief_summary>The objective study ass effectiveness safety narrowband-ultraviolet B ( NB-UVB ) treatment adult subject vitiligo .</brief_summary>
	<brief_title>Randomized , Split-body , Single-blinded Clinical Trial NB-UVB Treatment Vitiligo</brief_title>
	<detailed_description>Vitiligo chronic acquire cutaneous disease pigmentation affect patient ' quality life across degree involvement severity . Phototherapy clinically indicate treatment skin lesion . Treatments usually administer outpatient setting , typically three time per week . This proof-of-concept study well-designed prospective clinical study show efficacy NB-UVB phototherapy treatment vitiligo term repigmentation quality life . The follow proposed objective study : 1 . NB-UVB phototherapy improve vitiligo least 50 % repigmentation compare treatment affect area trunk extremities 24 week . 2 . NB-UVB phototherapy lead improvement quality life measure standardized quality life metric ( DLQI Skindex-29 ) 24 week .</detailed_description>
	<mesh_term>Vitiligo</mesh_term>
	<criteria>Adults 18 year old bilateral symmetrical vitiligo lesion , general good health determine Principal Investigator medical history physical exam . Able understand consent procedure Able comply protocol activity If woman , entry must : 1. postmenopausal , define 45 year age amenorrhea least 18 month , &gt; 45 year age amenorrhea least 6 month serum follicule stimulate hormone ( FSH ) level &gt; 40 IU/mL , surgically postmenopausal ( bilateral oophorectomy ) , 2. surgically sterile ( hysterectomy tubal ligation otherwise incapable pregnancy ) , 3 . If heterosexually active childbearing potential , practice highly effective method birth control , ( example include hormonal prescription oral contraceptive , contraceptive injection , contraceptive patch , intrauterine device , doublebarrier method ( e.g . condom , diaphragm , cervical cap , spermicidal foam , cream , gel ) , male partner sterilization consistent local regulation regard use birth control method subject participate clinical trial , duration participation study , 4 . Not heterosexually active Patients le 18 year old Patients able understand consent procedure Patients unable comply protocol activity Patients bilateral symmetrical vitiligo lesion NonEnglish speaker : study assessments/questionnaires/evaluations scientifically validate language English . Given lack translator 50 % patient encounter dermatology clinic interpreter ' limited time commitment one show , impossible safely enroll follow patient speak English . Phone translator impossible give write consent form , often exceed 10 page length . Patients photosensitive disorder medication demonstrate patient cause photosensitivity Patients receive concomitant phototherapy test sit Patient receive topical medication test site within 2 week study initiation Patient receive oral medication vitiligo within 4 week prior study initiation Receipt investigation agent within past 4 week ( within 5 half life ) prior study initiation Systemic corticosteroid therapy within past month Concurrent use drug list Appendix C .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>